审稿时间:暂无参考数据,审稿时间不确定!
见刊周期:-
温馨提示:以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。
1、投稿方式:在线投稿。
2、刊内网址(202503期):
http://www.keaipublishing.com/cn/journals/global-health-journal/
https://www.editorialmanager.com/glohj(投稿)
3、刊内电话:010-59787183
4、刊内邮箱:ghj@pmph.com
5、出刊日期:季刊,逢季末月30日出版。
6、官方微信公众号:全球健康杂志英文版(GHJ-PMPH)
2026年1月9日星期五
《全球健康杂志(英文)》投稿指南
【官网信息】
Guide for Authors
Introduction
Types of paper
Contributions
falling into the following categories will be considered for
publication: [ research articles, reviews, health policy, short
communications,editorials, commentaries, letters, perspectives, window
for China, bridging Belt and Road countries ].
Please
ensure that you select the appropriate article type from the list of
options when making your submission. Authors contributing to special
issues should ensure that they select the special issue article type
from this list.
Before you begin
Before You Begin
For
information on Ethics in Publishing and Ethical guidelines for journal
publication see https://www.elsevier.com/publishingethics and
https://www.elsevier.com/ethicalguidelines
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Submissions
to KeAi journals are automatically screened using iThenticate's
CrossCheck within the editorial system to detect plagiarism issues
including instances of overlapping and similar text in submitted
manuscripts. Details can be found here. High similarity papers will be
desk rejected.
Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must:
include a statement on ethics approval and consent (even where the need for approval was waived)
include the name of the ethics committee that approved the study and the committee's reference number if appropriate
All
materials must adhere to high ethical and animal welfare standards. Any
use of animals must be based on ethological knowledge and respect for
species-specific requirements for health and well-being. A statement
indicating that the protocol and procedures employed were ethically
reviewed and approved, and the name of the body giving approval, must be
included in the Methods section of the manuscript.
Consent for publication
If
your research or manuscript contains any individual person's data in
any form (including any individual details, images or videos), consent
for publication must be obtained from that person, or in the case of
children, their parent or legal guardian. All presentations of case
reports must have consent for publication.
Studies in humans and animals
the work involves the use of human subjects, the author should ensure
that the work described has been carried out in accordance with The Code
of Ethics of the World Medical Association (Declaration of Helsinki)
for experiments involving humans. The manuscript should be in line with
the Recommendations for the Conduct, Reporting, Editing and Publication
of Scholarly Work in Medical Journals and aim for the inclusion of
representative human populations (sex, age and ethnicity) as per those
recommendations. The terms sex and gender should be used correctly.
The
author should ensure that the manuscript contains a statement that all
procedures were performed in compliance with relevant laws and
institutional guidelines and have been approved by the appropriate
institutional committee(s). This statement should contain the date and
reference number of the ethical approval(s) obtained. Authors should
also include a statement in the manuscript that informed consent was
obtained for experimentation with human subjects. The privacy rights of
human subjects must always be observed.
journal will not accept manuscripts that contain data derived from
unethically sourced organs or tissue, including from executed prisoners
or prisoners of conscience, consistent with recommendations by Global
Rights Compliance on Mitigating Human Rights Risks in Transplantation
Medicine. For all studies that use human organs or tissues authors must
provide sufficient evidence that they were procured in line with WHO
Guiding Principles on Human Cell, Tissue and Organ Transplantation. The
source of the organs or tissues used in clinical research must be
transparent and traceable. Authors of manuscripts describing organ
transplantation must additionally declare within the manuscript:
that autonomous consent free from coercion was obtained from the donor(s) or their next of kin; and
that organs/tissues were not sourced from executed prisoners or prisoners of conscience.
animal experiments should comply with the ARRIVE guidelines and should
be carried out in accordance with the U.K. Animals (Scientific
Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU
for animal experiments, or the National Research Council's Guide for
the Care and Use of Laboratory Animals and the authors should clearly
indicate in the manuscript that such guidelines have been followed. The
sex of animals must be indicated, and where appropriate, the influence
(or association) of sex on the results of the study.
Declaration of interests
authors must disclose any financial and personal relationships with
other people or organizations that could inappropriately influence
(bias) their work. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert
testimony, patent applications/registrations, and grants or other
funding. Authors should complete the declaration of competing interest
statement using
https://www.elsevier.com/declaration-of-competing-interests and upload
to the submission system at the Attach/Upload Files step. Note: Please
do not convert the .docx template to another file type. Author
signatures are not required. If there are no interests to declare,
please choose the first option in the template. More Information
https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing/
Submission declaration and verification
Submission
of an article implies that the work described has not been published
previously (except in the form of an abstract or as part of a published
lecture or academic thesis or as an electronic preprint, see 'Multiple,
redundant or concurrent publication' section of our ethics policy for
more information), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly
or explicitly by the responsible authorities where the work was carried
out, and that, if accepted, it will not be published elsewhere in the
same form, in English or in any other language, including electronically
without the written consent of the copyright-holder. To verify
originality, your article automatically screened by the originality
detection service CrossCheck.
Use of inclusive language
Inclusive
language acknowledges diversity, conveys respect to all people, is
sensitive to differences, and promotes equal opportunities. Content
should make no assumptions about the beliefs or commitments of any
reader; contain nothing which might imply that one individual is
superior to another on the grounds of age, gender, race, ethnicity,
culture, sexual orientation, disability or health condition; and use
inclusive language throughout. Authors should ensure that writing is
free from bias, stereotypes, slang, reference to dominant culture and/or
cultural assumptions. We advise to seek gender neutrality by using
plural nouns ("clinicians, patients/clients") as default/wherever
possible to avoid using "he, she," or "he/she." We recommend avoiding
the use of descriptors that refer to personal attributes such as age,
gender, race, ethnicity, culture, sexual orientation, disability or
health condition unless they are relevant and valid. These guidelines
are meant as a point of reference to help identify appropriate language
but are by no means exhaustive or definitive.
write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who feel their English language
manuscript may require editing to eliminate possible grammatical or
spelling errors and to conform to correct scientific English may wish to
use the English Language Editing service available from Elsevier's
WebShop.
Preprints
note that preprints can be shared anywhere at any time, in line with
Elsevier's sharing policy. Sharing your preprints e.g. on a preprint
server will not count as prior publication (see 'Multiple, redundant or
concurrent publication' for more information).
Authorship Statement
transparency, we encourage authors to submit an author statement file
outlining their individual contributions to the paper using the relevant
CRediT roles: Conceptualization; Data curation; Formal analysis;
Funding acquisition; Investigation; Methodology; Project administration;
Resources; Software; Supervision; Validation; Visualization;
Roles/Writing - original draft; Writing - review & editing.
Authorship statements should be formatted with the names of authors
first and CRediT role(s) following.
Sample CRediT author statement
Zhang
San: Conceptualization, Methodology, Software Priya Singh.: Data
curation, Writing- Original draft preparation. Wang Wu: Visualization,
Investigation. Jan Jansen: Supervision. Ajay Kumar: Software,
Validation. Sun Qi: Writing- Reviewing and Editing.
More information can be viewed here.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before
the accepted manuscript is published: Requests to add or remove an
author, or to rearrange the author names, must be sent to the Journal
Manager from the corresponding author of the accepted manuscript and
must include: (a) the reason the name should be added or removed, or the
author names rearranged and (b) written confirmation (e-mail, fax,
letter) from all authors that they agree with the addition, removal or
rearrangement. In the case of addition or removal of authors, this
includes confirmation from the author being added or removed. Requests
that are not sent by the corresponding author will be forwarded by the
Journal Manager to the corresponding author, who must follow the
procedure as described above. Note that: (1) Journal Managers will
inform the Journal Editors of any such requests and (2) publication of
the accepted manuscript in an online issue is suspended until authorship
has been agreed.
After
the accepted manuscript is published: Any requests to add, delete, or
rearrange author names in an article published in an online issue will
follow the same policies as noted above and result in a corrigendum.
......
更多详见:
https://www.keaipublishing.com/en/journals/global-health-journal/guide-for-authors/